Pharma and Biotech Latest Insights

Curated Regulatory Intelligence Augmented by AI

Medicine And Poison Pharma

Pharma and Biotech

TGA Introduced Changes Applying to Evaluation of New Substances for Listed Medicines
21st March 2023

The TGA has introduced changes regarding the evaluation of new ingredients to be used in...

Amendment To The Clinical Trials Regulation (ctr) On Investigational Medicinal Products (imps) Labelling

Pharma and Biotech

Taiwan FDA published Guidelines for the Implementation of Drug Epidemiological Safety Research Using Electronic Health Care Data
7th February 2023

Real-world evidence is the latest international clinical application trend, which can be used to improve...

Herbal Products Thailand Published Draft On The Requirements Of Gmp Clearance Letter For Overseas Manufacturer

Pharma and Biotech

Thai FDA Issued Criteria, Methods and Conditions for Sampling of Herbal Products
2nd February 2023

The Thai Food and Drug Administration (TFDA) Issued Criteria, methods, and conditions for the sampling...

Amendment To The Clinical Trials Regulation (ctr) On Investigational Medicinal Products (imps) Labelling

Pharma and Biotech

EU Recommendations to Facilitate the Conduct of Decentralized Clinical Trials (DCTs)
1st February 2023

The European Commission (EC), the Heads of Medicines Agencies (HMA), and the European Medicines Agency...

Herbal Products Thailand Published Draft On The Requirements Of Gmp Clearance Letter For Overseas Manufacturer

Pharma and Biotech

Thailand Issued a Draft Notification on the Names of Substances Prohibited as Ingredients in Herbal Products
3rd January 2023

There are 3 lists of substances (plants, animals or parts of plants or animals), prohibited...

Amendment To The Clinical Trials Regulation (ctr) On Investigational Medicinal Products (imps) Labelling

Pharma and Biotech

EU: Amendment to the Clinical Trials Regulation (CTR) on Investigational Medicinal Products (IMPs) Labelling
13th December 2022

The European Commission (EC) revised the current labelling requirements provided in the Clinical Trials Regulation...

Cannabis In Bottled Pills

Pharma and Biotech

Thailand Issues the Notification Declaring the Inflorescence of Cannabis as a Controlled Herb
29th November 2022

This new Notification Re: Controlled Herb (Cannabis) B. E. 2565 (2022) dated 11th Nov 2022...

Medicine And Poison Pharma

Pharma and Biotech

TGA – Standard for Serialization and Data Matrix Codes for Medicines Comes into Effect on Jan 2023
28th November 2022

The Therapeutic Goods (Medicines – Standard for Serialisation and Data Matrix Codes) (TGO 106) Order...

India Proposed Amendment To New Drugs And Clinical Trials Rules

Pharma and Biotech

India Proposed Amendment to New Drugs and Clinical Trials Rules
23rd November 2022

The India Ministry of Health and Family Welfare (MoHFW) proposed an amendment to New Drugs...

New Vaccine To Protect People In The Eu And Worldwide Against Dengue

Pharma and Biotech

New Vaccine to Protect People in the EU and Worldwide against Dengue
2nd November 2022

On 13 October 2022, the Committee for Medicinal Products for Human Use (CHMP) of the...

Have a
regulatory affairs
challenge?

Regulatory Affair Icon

"*" indicates required fields

I want to...

I want to*
Name*
This field is for validation purposes and should be left unchanged.